Developer of human gene-based therapies. The company has developed a platform to bring new disease-modifying therapies to patients with severe disorders. The company's pipeline includes gene-based therapies for lipoprotein lipase deficiency, or LPLD, Sanfilippo B, Parkinson's Disease and Hemophilia B. Lire la suite
Our ability to tranform peoples' lives
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
They care about our employees
Other Employee Reviews for uniQure
×